150 related articles for article (PubMed ID: 19536895)
1. Molecular dynamics simulations and functional characterization of the interactions of the PAR2 ectodomain with factor VIIa.
Zhang Q; Petersen HH; Ostergaard H; Ruf W; Olson AJ
Proteins; 2009 Nov; 77(3):559-69. PubMed ID: 19536895
[TBL] [Abstract][Full Text] [Related]
2. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.
Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC
J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709
[TBL] [Abstract][Full Text] [Related]
3. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
Rothmeier AS; Versteeg HH; Ruf W
J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
[TBL] [Abstract][Full Text] [Related]
4. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W
Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
6. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.
Albrektsen T; Sørensen BB; Hjortø GM; Fleckner J; Rao LV; Petersen LC
J Thromb Haemost; 2007 Aug; 5(8):1588-97. PubMed ID: 17470200
[TBL] [Abstract][Full Text] [Related]
8. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
[TBL] [Abstract][Full Text] [Related]
9. Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.
Guo D; Zhou H; Wu Y; Zhou F; Xu G; Wen H; Zhang X
Tumour Biol; 2011 Oct; 32(5):921-30. PubMed ID: 21625939
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor activates allosteric networks in factor VIIa through structural and dynamic changes.
Madsen JJ; Persson E; Olsen OH
J Thromb Haemost; 2015 Feb; 13(2):262-7. PubMed ID: 25403348
[TBL] [Abstract][Full Text] [Related]
11. The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
Carneiro-Lobo TC; Schaffner F; Disse J; Ostergaard H; Francischetti IM; Monteiro RQ; Ruf W
J Thromb Haemost; 2012 Sep; 10(9):1849-58. PubMed ID: 22823596
[TBL] [Abstract][Full Text] [Related]
12. Structural modulation of factor VIIa by full-length tissue factor (TF
Prasad R; Sen P
J Biomol Struct Dyn; 2018 Feb; 36(3):621-633. PubMed ID: 28150568
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling.
Mandal SK; Pendurthi UR; Rao LV
Blood; 2007 Jul; 110(1):161-70. PubMed ID: 17384202
[TBL] [Abstract][Full Text] [Related]
14. TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.
Hu L; Xia L; Zhou H; Wu B; Mu Y; Wu Y; Yan J
Tumour Biol; 2013 Oct; 34(5):2573-81. PubMed ID: 23616010
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Marutsuka K; Hatakeyama K; Sato Y; Yamashita A; Sumiyoshi A; Asada Y
Thromb Res; 2002 Sep; 107(5):271-6. PubMed ID: 12479889
[TBL] [Abstract][Full Text] [Related]
16. The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa.
Eriksson O; Ramström M; Hörnaeus K; Bergquist J; Mokhtari D; Siegbahn A
J Biol Chem; 2014 Nov; 289(47):32379-91. PubMed ID: 25281742
[TBL] [Abstract][Full Text] [Related]
17. Contribution of allosteric disulfide in the structural regulation of membrane-bound tissue factor-factor VIIa binary complex.
Prasad R; Banerjee S; Sen P
J Biomol Struct Dyn; 2019 Sep; 37(14):3707-3720. PubMed ID: 30238846
[TBL] [Abstract][Full Text] [Related]
18. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
Wiiger MT; Prydz H
Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
[TBL] [Abstract][Full Text] [Related]
19. Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion.
Paul S; Das K; Ghosh A; Chatterjee A; Bhoumick A; Basu A; Sen P
J Thromb Haemost; 2023 Dec; 21(12):3522-3538. PubMed ID: 37579880
[TBL] [Abstract][Full Text] [Related]
20. Alteration in endothelial permeability occurs in response to the activation of PAR2 by factor Xa but not directly by the TF-factor VIIa complex.
Benelhaj NE; Maraveyas A; Featherby S; Collier MEW; Johnson MJ; Ettelaie C
Thromb Res; 2019 Mar; 175():13-20. PubMed ID: 30677622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]